Aclarion (ACON) vs Sera Prognostics (SERA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sera Prognostics is the larger company by market cap ($81.7 million vs $6.8 million), about 12.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ACON | SERA |
|---|---|---|
| Share price | $2.35 | $2.07 |
| Market cap | $6.77M | $81.66M |
| 1-day change | +2.40% | +0.98% |
| YTD return | — | -29.83% |
| 1-year return | — | -36.31% |
| 5-year return | — | -80.92% |
| EPS (TTM) | $-7.61 | $-0.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.03 | $3.95 |
| 52-week low | $1.95 | $1.56 |
| Distance from 52-week high | -80.47% | -47.59% |
| Average volume | 52.96K | 28.59K |
| Shares outstanding | 2.88M | 38.48M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sera Prognostics is about 12.1 times larger than Aclarion by market value ($81.66M vs $6.77M).
ACON vs SERA FAQ
Which is bigger, Aclarion or Sera Prognostics?
Sera Prognostics (SERA) is larger, with a market capitalization of $81.66M compared with $6.77M for Aclarion (ACON).
Are Aclarion and Sera Prognostics in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.